Apollon Wealth Management LLC Makes New $280,000 Investment in Agilent Technologies, Inc. (NYSE:A)

Apollon Wealth Management LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, HoldingsChannel reports. The firm bought 1,885 shares of the medical research company’s stock, valued at approximately $280,000.

Several other hedge funds also recently bought and sold shares of A. Massachusetts Financial Services Co. MA lifted its position in Agilent Technologies by 5.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock valued at $1,952,832,000 after acquiring an additional 809,149 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in Agilent Technologies by 13.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company’s stock valued at $1,242,956,000 after acquiring an additional 1,042,926 shares in the last quarter. Van ECK Associates Corp lifted its position in Agilent Technologies by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after acquiring an additional 183,716 shares in the last quarter. Impax Asset Management Group plc lifted its position in Agilent Technologies by 8.2% in the 3rd quarter. Impax Asset Management Group plc now owns 2,667,616 shares of the medical research company’s stock valued at $396,088,000 after acquiring an additional 203,234 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in Agilent Technologies by 2.3% in the 2nd quarter. Victory Capital Management Inc. now owns 2,386,039 shares of the medical research company’s stock valued at $309,302,000 after acquiring an additional 52,550 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Evercore ISI lifted their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. TD Cowen lifted their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Wells Fargo & Company assumed coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price target on the stock. Stifel Nicolaus reiterated a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Finally, Barclays lifted their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research note on Tuesday, October 15th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $144.36.

Insider Buying and Selling at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. The trade was a 19.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. This represents a 7.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,995 shares of company stock valued at $1,739,510 in the last quarter.

Agilent Technologies Stock Down 2.4 %

Shares of A opened at $127.07 on Monday. Agilent Technologies, Inc. has a 52 week low of $112.06 and a 52 week high of $155.35. The firm has a market cap of $36.51 billion, a P/E ratio of 26.36, a price-to-earnings-growth ratio of 5.59 and a beta of 1.07. The firm’s 50-day simple moving average is $138.73 and its 200 day simple moving average is $138.00. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies’s quarterly revenue was down 5.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.43 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is currently 19.50%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.